ArticleCommunications medicine2026
Cannabis consumption is associated with altered steroid metabolism in young men.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCannabis use has been hypothesized to alter endocrine function. We aimed at investigating this hypothesis through extended steroid profiling in young men.
methodsUsing liquid chromatography - tandem mass spectrometry (LC-MS/MS), 70 endogenous steroids were reliably identified in serum samples from 47 cannabis consumers and 47 controls. Seven major steroids were subject to absolute quantification, while the others were considered as relative concentrations.
resultsThis cross-sectional study shows a global increase in androgen levels among cannabis consumers. Androstenedione (A4), testosterone (T), and dihydrotestosterone (DHT) are among the most significantly increased steroids. In contrast, C11-oxy androgens show no significant change upon cannabis use. This pattern suggests that phytocannabinoids might selectively affect gonadal androgen synthesis without altering adrenal or peripheral pathways, possibly via direct effects on the testes, or disruption of the hypothalamic-pituitary-gonadal (HPG) axis function. Additionally, two progesterone metabolites, 11β-hydroxyprogesterone (11β-OHP4) and 5β-dihydroprogesterone (5β-DHP4), are markedly elevated in cannabis consumers. When the cannabis user group is stratified according to the corresponding usage biomarkers, 11β-OHP4 proves to be a biomarker of general exposure, whereas 5β-DHP4 displays a dose-dependent relationship.
conclusionsThese findings highlight the value of extended steroid profiling for investigating hormonal variations and evidence a possible link between cannabis consumption and altered male endocrine function.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.